Metastatic Gastric Adenocarcinoma Not Yet Recruiting Phase 2 / 3 Trials for Ramucirumab (DB05578)

Also known as: Adenocarcinoma gastric / Adenocarcinoma of stomach (disorder)

IndicationStatusPhase
DBCOND0074521 (Metastatic Gastric Adenocarcinoma)Not Yet Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT06203600Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, The PARAMMUNE TrialTreatment